Vials of freeze-dried intradermal BCG (Bacillus Calmette-Guerin) vaccine,4 of 10, boxed, each providing ten 0.1ml doses when hydrated, for protection against tuberculosis, by Evans Medical Ltd. Leatherhead, England, 1994

The BCG (Bacillus Calmette-Guérin) vaccine is used to protect against tuberculosis. The vaccine was developed by French bacteriologists Albert Calmette (1863-1933) and Camille Guérin (1872-1961) at the Pasteur Institute, Lille, France, in 1921. The vaccine was successfully used in France but did not go into widespread use until after the Second World War.

By freeze-drying the vaccines, the treatment can safely be transported over long distances and diluted when needed.

Vials of freeze-dried intradermal BCG (Bacillus Calmette-Guerin) vaccine, 3 of 10, each providing ten 0.1ml doses when hydrated, for protection against tuberculosis, by Evans Medical Ltd., Leatherhead, Surrey, England, 1994.

The BCG (Bacillus Calmette-Guérin) vaccine is used to protect against tuberculosis. The vaccine was developed by French bacteriologists Albert Calmette (1863-1933) and Camille Guérin (1872-1961) at the Pasteur Institute, Lille, France, in 1921. The vaccine was successfully used in France but did not go into widespread use until after the Second World War.

By freeze-drying the vaccines, the treatment can safely be transported over long distances and diluted when needed.

Vials of freeze-dried intradermal BCG (Bacillus Calmette-Guerin) vaccine,1 of 10, boxed, each providing ten 0.1ml doses when hydrated, for protection against tuberculosis, by Evans Medical Ltd. Leatherhead, England, 1994

The BCG (Bacillus Calmette-Guérin) vaccine is used to protect against tuberculosis. The vaccine was developed by French bacteriologists Albert Calmette (1863-1933) and Camille Guérin (1872-1961) at the Pasteur Institute, Lille, France, in 1921. The vaccine was successfully used in France but did not go into widespread use until after the Second World War.

By freeze-drying the vaccines, the treatment can safely be transported over long distances and diluted when needed.

Vials of freeze-dried intradermal BCG (Bacillus Calmette-Guerin) vaccine,1 of 10, boxed, each providing ten 0.1ml doses when hydrated, for protection against tuberculosis, by Evans Medical Ltd. Leatherhead, England, 1994

The BCG (Bacillus Calmette-Guérin) vaccine is used to protect against tuberculosis. The vaccine was developed by French bacteriologists Albert Calmette (1863-1933) and Camille Guérin (1872-1961) at the Pasteur Institute, Lille, France, in 1921. The vaccine was successfully used in France but did not go into widespread use until after the Second World War.

By freeze-drying the vaccines, the treatment can safely be transported over long distances and diluted when needed.

Vials of freeze-dried intradermal BCG (Bacillus Calmette-Guerin) vaccine,1 of 10, boxed, each providing ten 0.1ml doses when hydrated, for protection against tuberculosis, by Evans Medical Ltd. Leatherhead, England, 1994

The BCG (Bacillus Calmette-Guérin) vaccine is used to protect against tuberculosis. The vaccine was developed by French bacteriologists Albert Calmette (1863-1933) and Camille Guérin (1872-1961) at the Pasteur Institute, Lille, France, in 1921. The vaccine was successfully used in France but did not go into widespread use until after the Second World War.

By freeze-drying the vaccines, the treatment can safely be transported over long distances and diluted when needed. Made by Evans Medical Ltd, the small glass bottle gives one dose of the vaccine when diluted. It is shown here with a ten-dose bottle of the vaccine (1994-394 Pt3).